1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Enanta Pharmaceuticals Inc (ENTA)
  7. Quote


Enanta Pharmaceuticals Stock Price

-1.51 (-1.79%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 144,001
Bid Price 80.01
Ask Price 85.00
News (2)
Day High 85.585


52 Week Range


Day Low 81.68
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Enanta Pharmaceuticals Inc ENTA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.51 -1.79% 82.67 19:50:07
Open Price Low Price High Price Close Price Prev Close
84.91 81.68 85.585 82.67 84.18
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,833 144,001 $ 82.98 $ 11,949,017 - 40.32 - 102.00
Last Trade Time Type Quantity Stock Price Currency
18:03:24 3 $ 82.67 USD


Draw Mode:

Enanta Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.68B 20.32M 16.03M $ 97.07M $ -79.00M -3.91 -21.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -8.87k 5.90%

more financials information »

Enanta Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENTA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week86.0492.9081.6887.81337,024-3.37-3.92%
1 Month96.64102.0073.7188.52263,634-13.97-14.46%
3 Months55.82102.0053.5978.11187,22126.8548.1%
6 Months46.12102.0040.3762.62172,38836.5579.25%
1 Year42.29102.0040.3256.37156,78040.3895.48%
3 Years80.73107.0038.4063.61181,5791.942.4%
5 Years31.99127.7725.9264.31192,78750.68158.42%

Enanta Pharmaceuticals Description

Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Your Recent History
Enanta Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.